Markets.com Logo

CARA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    17.5264$
  • Previous Close
    18.3429$
  • 52 Week Change
    21.86$
  • Day Range
    -0.82$
  • 52 Week High/Low
    8.1252$ - 29.9808$
  • Dividend Per Share
    --
  • Market cap
    8 111 K$
  • EPS
    -1.6799
  • Beta
    0.413
  • Volume
    --

About

CARA.US represents the common stock of Cara Therapeutics, Inc. This biopharmaceutical company focuses on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara Therapeutics is a publicly traded company, and its stock is listed on the Nasdaq Stock Market under the ticker symbol CARA. Investors can trade shares of Cara Therapeutics through various brokerage accounts.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Cara Therapeutics' stock price, CARA.US, is influenced by several factors: Clinical Trial Results: Positive clinical trial outcomes for Cara's pipeline drugs, especially Korsuva, typically drive the stock price up. Conversely, failures or setbacks depress it. Regulatory Decisions: FDA approvals or rejections significantly impact investor sentiment and the stock's value. Approvals lead to potential revenue streams. Market Conditions: Overall market trends, especially in the biotechnology sector, influence CARA.US. Bull markets boost, bear markets depress. Competition: The emergence of competing pain management drugs affects Korsuva's market potential and CARA's valuation. Financial Performance: Cara's cash burn rate, revenue (primarily from collaborations), and overall financial health play a role in investor confidence. Partnerships/Collaborations: Deals with pharmaceutical companies for development or commercialization can positively impact the stock price. Analyst Ratings: Upgrades or downgrades from financial analysts can influence investor behavior and price movements.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--